In this week's edition, anxiety, depression worse among older men with vision impairment; emerging therapeutics may improve outcomes in pediatric patients with rare disorders; glioblastoma presents roadblock to successful immunotherapy; and more. Read the full coverage here: MRI findings key pathology markers of 4R-tauopathies Emerging therapeutics may improve outcomes in pediatric patients with rare disorders Together Senior Health launches platform to reduce memory loss in AD, dementia Anxiety, depression worse among older men with vision impairment Glioblastoma presents roadblock to successful immunotherapy References: Carlos AF, et al. Tau histopathological lesion type correlates of structural magnetic resonance imaging and diffusion tensor imaging biomarkers in 4-repeat tauopathies. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle. Emrick L, et al. Emerging therapeutics for rare pediatric genetic disorders. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle. Press Release Gascoyne B, et al. Int Health. 2022;doi:10.1093/inthealth/ihab070 Kumthekar P. AAN year in review: neuro oncology. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.

Ver todos los episodios